Nanocrystalline Silver Technology
Nucryst Pharmaceuticals develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology.
Nucryst has a successful nanocrystalline silver coating business and is developing a pipeline of potential products to target diseases involving infection and/or inflammation.

05/06/09 NUCRYST Announces 2009 First Quarter Financial Results  MORE

02/17/09 NUCRYST Announces Fourth Quarter and Year End 2008 Financial Results  MORE

5/6/09 NUCRYST Pharmaceuticals Corp. Conference Call to Discuss 2009 First Quarter Results   MORE >

To be notified by email of upcoming events and press releases MORE >
© Copyright 2004 NUCRYST Pharmaceuticals Corp. All rights reserved. legal
SILCRYST™ is a trademark of NUCRYST Pharmaceuticals Corp. and Acticoat™ is trademark of Smith & Nephew plc